 SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 GLOBE NEWSWIRE -- Sutro Biopharma, Inc. Sutro or the Company NASDAQ: STRO, a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates ADCs, today announced that Bill Newell, Chief Executive Officer, will present at the 2022 Wedbush PacGrow Healthcare Conferences panel discussion, ADCs - Take Me to Your Tumor on Wednesday, August 10, 2022, at 2:20 p.m. ET 11:20 a.m. PT. 